Cargando…
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET
Detecting tumor lesions <1 cm in size using current imaging methods remains a clinical challenge, especially in pancreatic cancer. Previously, we developed a method to identify pancreatic tumor lesions ≥3 mm using positron emission tomography (PET) with an intraperitoneally administered (64)Cu-la...
Autores principales: | Matsumoto, Hiroki, Igarashi, Chika, Tachibana, Tomoko, Hihara, Fukiko, Shinada, Mitsuhiro, Waki, Atsuo, Yoshida, Sei, Naito, Kenichiro, Kurihara, Hiroaki, Ueno, Makoto, Ito, Kimiteru, Higashi, Tatsuya, Yoshii, Yukie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504034/ https://www.ncbi.nlm.nih.gov/pubmed/36145676 http://dx.doi.org/10.3390/pharmaceutics14091928 |
Ejemplares similares
-
Process to Remove the Size Variants Contained in the Antibody–Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64
por: Yoshii, Yukie, et al.
Publicado: (2023) -
Characterization and Stabilization of a New (64)Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography
por: Matsumoto, Hiroki, et al.
Publicado: (2021) -
Evaluation of (64)Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates
por: Matsumoto, Hiroki, et al.
Publicado: (2021) -
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized (64)Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study
por: Hihara, Fukiko, et al.
Publicado: (2022) -
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free (225)Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2021)